Leading the Way in Life Science Technologies

GEN Exclusives

More »

December 1, Vol. 28, No. 21

  • Feature Articles

    • Doubts Stymie Implementation of RFID
    • Angelo DePalma, Ph.D.
    • Radiofrequency identification (RFID) has been the darling technology of supply-chain gurus since at least 2003, but industry in general, and pharmaceutical and biotechnology companies in particular, have been slow to adopt it, even for the most basic track and trace ... more »
    • Zeroing in on PI3K Pathway
    • Nina Flanagan
    • Although the term “signal transduction” was coined back in 1972, cell-signaling switches have only recently become one of the hottest targets in cancer research The latest star is the phosphoinositide 3-kinase (PI3-kinase) pathway—playing key roles in angiogenesis, cell growth, differentiation, ... more »
    • Update on Emerging Biobanking Practices
    • Catherine Shaffer
    • Biotech and pharmaceutical companies are not yet fully comfortable thinking of biological samples as assets However, new biomarker discovery initiatives as well as large-scale genome projects and disease consortia have encouraged the biobank movement, forcing the rapidly changing industry to ... more »
    • Improving Delivery thru Nanotechnology
    • Gail Dutton
    • Nanotechnology has the potential to dramatically improve the drug delivery model, resulting in new classes of therapeutics as well as diagnostics Some of the advances and opportunities were discussed earlier this year at the “NSTI BioNano” conference... more »